Literature DB >> 28103389

The use of antioxidants in the treatment of traumatic brain injury.

Whitney Venegoni1, Qiuhua Shen2, Amanda R Thimmesch2, Meredith Bell2, John B Hiebert2, Janet D Pierce2.   

Abstract

AIMS: The aim of this study was to discuss secondary traumatic brain injury, the mitochondria and the use of antioxidants as a treatment.
BACKGROUND: One of the leading causes of death globally is traumatic brain injury, affecting individuals in all demographics. Traumatic brain injury is produced by an external blunt force or penetration resulting in alterations in brain function or pathology. Often, with a traumatic brain injury, secondary injury causes additional damage to the brain tissue that can have further impact on recovery and the quality of life. Secondary injury occurs when metabolic and physiologic processes alter after initial injury and includes increased release of toxic free radicals that cause damage to adjacent tissues and can eventually lead to neuronal necrosis. Although antioxidants in the tissues can reduce free radical damage, the magnitude of increased free radicals overwhelms the body's reduced defence mechanisms. Supplementing the body's natural supply of antioxidants, such as coenzyme Q10, can attenuate oxidative damage caused by reactive oxygen species.
DESIGN: Discussion paper. DATA SOURCES: Research literature published from 2011-2016 in PubMed, CINAHL and Cochrane. IMPLICATIONS FOR NURSING: Prompt and accurate assessment of patients with traumatic brain injury by nurses is important to ensure optimal recovery and reduced lasting disability. Thus, it is imperative that nurses be knowledgeable about the secondary injury that occurs after a traumatic brain injury and aware of possible antioxidant treatments.
CONCLUSION: The use of antioxidants has potential to reduce the magnitude of secondary injury in patients who experience a traumatic brain injury.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  antioxidant; mitochondria; nursing; oxidative stress; secondary injury; traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 28103389     DOI: 10.1111/jan.13259

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  5 in total

1.  Coenzyme Q10 alleviates tacrolimus-induced mitochondrial dysfunction in kidney.

Authors:  Ji Hyun Yu; Sun Woo Lim; Kang Luo; Sheng Cui; Yi Quan; Yoo Jin Shin; Kyung Eun Lee; Hong Lim Kim; Eun Jeong Ko; Byung Ha Chung; Ju Hwan Kim; Sang J Chung; Chul Woo Yang
Journal:  FASEB J       Date:  2019-08-20       Impact factor: 5.191

2.  Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury.

Authors:  Kang Luo; Ji Hyun Yu; Yi Quan; Yoo Jin Shin; Kyung Eun Lee; Hong Lim Kim; Eun Jeong Ko; Byung Ha Chung; Sun Woo Lim; Chul Woo Yang
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

3.  Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin.

Authors:  Bahareh Hakiminia; Babak Alikiaie; Fariborz Khorvash; Sarah Mousavi
Journal:  Adv Pharm Bull       Date:  2021-04-03

4.  Protective Effect of Lutein/Zeaxanthin Isomers in Traumatic Brain Injury in Mice.

Authors:  Mehmet Yalcin Gunal; Ayse Arzu Sakul; Ahmet Burak Caglayan; Fusun Erten; Oznur Ece Durmaz Kursun; Ertugrul Kilic; Kazim Sahin
Journal:  Neurotox Res       Date:  2021-06-15       Impact factor: 3.911

5.  MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.

Authors:  A Theadom; S Barker-Collo; K M Jones; P Parmar; R Bhattacharjee; V L Feigin
Journal:  Eur J Neurol       Date:  2018-04-27       Impact factor: 6.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.